![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.7, Iss.6, 1997-06, pp. : 589-599
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Li Xinru Li Pingzhu Zhang Yanhui Zhou Yanxia Chen Xingwei Huang Yanqing Liu Yan
Pharmaceutical Research, Vol. 27, Iss. 8, 2010-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Multi-drug resistance and cancer
By Atalay Can
Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 5, 2007-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance
Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 18, 2017-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacological Strategies for Overcoming Multidrug Resistance
Current Drug Targets, Vol. 7, Iss. 7, 2006-07 ,pp. :